These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 653637)

  • 1. A simple assay for human factor IX: use of canine hemophilia B plasma as substrate.
    Goldsmith JC; Chung KS; Roberts HR
    Thromb Res; 1978 Mar; 12(3):497-502. PubMed ID: 653637
    [No Abstract]   [Full Text] [Related]  

  • 2. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
    Elodi S
    Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
    [No Abstract]   [Full Text] [Related]  

  • 3. Performances of an artificial reagent for the one-stage factor IX assay.
    Meunier L; Allain JP; Frommel D
    Thromb Diath Haemorrh; 1975 Jun; 33(3):547-52. PubMed ID: 1154311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor IX in normal and haemophilia B plasma.
    Somer JB; Castaldi PA
    Br J Haematol; 1970 Feb; 18(2):147-59. PubMed ID: 5439522
    [No Abstract]   [Full Text] [Related]  

  • 5. Standardization of FVIII & FIX assays.
    Barrowcliffe TW
    Haemophilia; 2003 Jul; 9(4):397-402. PubMed ID: 12828675
    [No Abstract]   [Full Text] [Related]  

  • 6. [An unified method of one-stage quantitative analysis of factors VIII and IX. I. (Results of the studies of the working group of the All-Union Problem-Solving Commission on "Pathology of hemostasis")].
    Barkagan ZS
    Gematol Transfuziol; 1991 Apr; 36(4):33-5. PubMed ID: 1906034
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of factor IX analysis in blood coagulation tests].
    Kakishita E; Nishida Y
    Nihon Rinsho; 1989 Dec; 48 Suppl():834-6. PubMed ID: 2622013
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution to the technic of factor IX activity determination. Antihemophilic globulin B; Christmas factor; PTC].
    Kurme A; Landbeck G
    Klin Wochenschr; 1967 Aug; 45(15):777-82. PubMed ID: 4873694
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory prediction of the carrier state in hemophilia B: role of replication of assays.
    Lipworth L; Tiarks CY; Rice CA; Pechet L
    Am J Clin Pathol; 1979 Dec; 72(6):1000-4. PubMed ID: 391020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of the coagulation factor IX following intravenous application of Tralysol in persons with Hematophilia B].
    Bierstedt P
    Klin Wochenschr; 1970 May; 48(10):632-4. PubMed ID: 5314171
    [No Abstract]   [Full Text] [Related]  

  • 11. [Factor IX assays in treated hemophilia B patients].
    Pouplard C; Jeanpierre E; Lasne D; Le Cam Duchez V; Eschwege V; Flaujac C; Galinat H; Harzallah I; Proulle V; Smahi M; Sobas F; Ternisien C; Toulon P; Voisin S; Nougier C;
    Ann Biol Clin (Paris); 2019 Feb; 77(1):41-52. PubMed ID: 30799297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Method of determining factor IX activity].
    Taran LD; Radionova MN
    Ukr Biokhim Zh (1978); 1996; 68(5):98-102. PubMed ID: 9229862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs.
    Kay MA; Rothenberg S; Landen CN; Bellinger DA; Leland F; Toman C; Finegold M; Thompson AR; Read MS; Brinkhous KM
    Science; 1993 Oct; 262(5130):117-9. PubMed ID: 8211118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative two-stage assay for factor IX (Christmas factor) using plasma from dogs with Christmas disease.
    Aronson DL; Dodds WJ; Mustafa AJ
    Thromb Diath Haemorrh; 1972 Jul; 27(3):529-34. PubMed ID: 4662614
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune reactive factor IX in acquired factor IX deficiency.
    Lechner K
    Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
    [No Abstract]   [Full Text] [Related]  

  • 17. An investigation of three patients with Christmas disease due to an abnormal type of factor IX.
    Denson KW; Biggs R; Mannucci PM
    J Clin Pathol; 1968 Mar; 21(2):160-5. PubMed ID: 4972271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Electroimmunoassay of human coagulation factor IX in the detection of variants of haemophilia B.
    Orstavik K; Osterud B
    Thromb Diath Haemorrh; 1975 Sep; 34(1):322-3. PubMed ID: 1188733
    [No Abstract]   [Full Text] [Related]  

  • 19. A micromethod for clotting tests and coagulation factor assays.
    Exner T; Margolis J; Rickard KA
    Clin Lab Haematol; 1980; 2(3):227-30. PubMed ID: 6775862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.
    Bertina RM; Van Der Linden IK
    J Lab Clin Med; 1982 Nov; 100(5):695-704. PubMed ID: 7130828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.